As of 2026-06-10, the EV/EBITDA ratio of Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd (002864.SZ) is 20.20. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. 002864.SZ's latest enterprise value is 1,998.78 mil CNY. 002864.SZ's TTM EBITDA according to its financial statements is 98.94 mil CNY. Dividing these 2 quantities gives us the above 002864.SZ EV/EBITDA ratio.
| Range | Selected | |
| Trailing P/E multiples | 26.2x - 54.7x | 41.4x |
| Forward P/E multiples | 14.2x - 18.0x | 15.8x |
| Fair Price | 29.17 - 60.31 | 39.67 |
| Upside | 3.6% - 114.2% | 40.9% |
| Date | EV/EBITDA |
| 2026-05-27 | 20.51 |
| 2026-05-26 | 20.63 |
| 2026-05-25 | 21.22 |
| 2026-05-22 | 21.45 |
| 2026-05-21 | 21.35 |
| 2026-05-20 | 22.38 |
| 2026-05-19 | 22.70 |
| 2026-05-18 | 22.69 |
| 2026-05-15 | 22.98 |
| 2026-05-14 | 23.23 |
| 2026-05-13 | 23.91 |
| 2026-05-12 | 22.93 |
| 2026-05-11 | 23.92 |
| 2026-05-08 | 23.64 |
| 2026-05-07 | 22.93 |
| 2026-05-06 | 22.50 |
| 2026-04-30 | 22.44 |
| 2026-04-29 | 22.51 |
| 2026-04-28 | 21.75 |
| 2026-04-27 | 22.53 |
| 2026-04-24 | 22.38 |
| 2026-04-23 | 22.46 |
| 2026-04-22 | 22.72 |
| 2026-04-21 | 23.19 |
| 2026-04-20 | 23.79 |
| 2026-04-17 | 24.12 |
| 2026-04-16 | 24.78 |
| 2026-04-15 | 24.63 |
| 2026-04-14 | 24.25 |
| 2026-04-13 | 24.33 |
| 2026-04-10 | 25.34 |
| 2026-04-09 | 25.32 |
| 2026-04-08 | 26.65 |
| 2026-04-07 | 26.10 |
| 2026-04-03 | 25.71 |
| 2026-04-02 | 26.67 |
| 2026-04-01 | 26.89 |
| 2026-03-31 | 25.82 |
| 2026-03-30 | 26.44 |
| 2026-03-27 | 25.53 |
| 2026-03-26 | 24.84 |
| 2026-03-25 | 24.92 |
| 2026-03-24 | 24.69 |
| 2026-03-23 | 23.62 |
| 2026-03-20 | 26.48 |
| 2026-03-19 | 26.20 |
| 2026-03-18 | 26.77 |
| 2026-03-17 | 25.77 |
| 2026-03-16 | 26.31 |
| 2026-03-13 | 25.84 |